Canara Robeco Multi Cap Fund
The scheme is seks to generate long-term capital appreciation through diversifiedinvestments in equity & equity related instruments across large cap, mid cap, and small cap stocks
Growthvine rating: 3/5 — ranked #14 of 35 in category.
Fund basics
| Category | Equity: Multi Cap |
|---|
| NAV | ₹13.89 (as of 2026-10-22) |
|---|
| AUM | ₹5,673 Cr |
|---|
| Expense ratio | 1.58% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Shridatta Bhandwaldar |
|---|
| Exit load | 1% for redemption within 365 days |
|---|
Performance & risk
| Sharpe ratio | 0.41 |
|---|
| Standard deviation | 15.96% |
|---|
| Max drawdown | −18.79% |
|---|
| Alpha | 3.55 |
|---|
| Beta | 0.92 |
|---|
Over 5 years, captured 94.9% of NIFTY500 Multicap 50:25:25's upside and 91.1% of its downside.
Market cap allocation
| Large cap | 42.2% |
|---|
| Mid cap | 27.6% |
|---|
| Small cap | 30.2% |
|---|
Concentration
| Top 5 holdings | 14.7% |
|---|
| Top 10 holdings | 23.6% |
|---|
| Total holdings | 116 |
|---|
| Index overlap | 40.7% |
|---|
| Active share | 59.3% |
|---|
Top holdings
- HDFC Bank Ltd. — 4.3%
- ICICI Bank Ltd. — 3.5%
- Bharti Airtel Ltd. — 2.5%
- TREPS — 2.4%
- Eternal Limited — 2.3%
- Ajanta Pharma Ltd. — 2.1%
- TBO TEK LIMITED — 1.9%
- Lenskart Solutions Limited — 1.8%
- Larsen & Toubro Limited — 1.8%
- Infosys Ltd — 1.7%
Top sectors
- Banking & Financial — 20.9%
- Pharma & Biotech — 8.1%
- Retail — 8.1%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −6.8% | Q4 (Bottom) | #29 of 34 |
| 2025 | 5.1% | Q1 (Top) | #7 of 31 |
| 2024 | 21.5% | Q3 | #16 of 24 |